Global Healthcare Antimicrobial Plastics Market Insights, Forecast to 2025

Published On: August 2018 | Report ID: 79460 | Category: Chemicals and MaterialsPages: 100

This report researches the worldwide Healthcare Antimicrobial Plastics market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.

This study categorizes the global Healthcare Antimicrobial Plastics breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Healthcare antimicrobial plastic are a type of polymer material infused with antimicrobial agents and additives such as organic-metallic biocides and arseni-based oxybisphenox arsine (OBPA). Antimicrobial plastic are mainly used to kill microorganisms such as bacteria, algae, and fungi, and inhibit their growth in the end-use products.

Global Healthcare Antimicrobial Plastics market size will increase to xx Million US$ by 2025, from xx Million US$ in 2017, at a CAGR of xx% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Healthcare Antimicrobial Plastics.

This report focuses on the top manufacturers' Healthcare Antimicrobial Plastics capacity, production, value, price and market share of Healthcare Antimicrobial Plastics in global market. The following manufacturers are covered in this report:

BASF SE (Germany)

Bayer MaterialScience AG (Germany)

The Dow Chemical Company (US)

Clariant AG (Switzerland)

Lonza Group AG (Switzerland)

Microban International (US)

Parx Plastic BV (The Netherlands)

King Plastic Corporation (US)

Biocote (UK)

Milliken Chemical (US)

Sanitized AG (Switzerland)

PolyOne Corporation (US)

Ticona Engineering Polymers (US)

DSM (Netherlands)

Doeflex-Vitapol (UK)

Healthcare Antimicrobial Plastics Breakdown Data by Type

Commodity Plastic

Engineering Plastic

High Performance Plastic

Healthcare Antimicrobial Plastics Breakdown Data by Application

Hospital

Pharmacy

Household

Medical Research

Healthcare Antimicrobial Plastics Production Breakdown Data by Region

United States

Europe

China

Japan

Other Regions

Healthcare Antimicrobial Plastics Consumption Breakdown Data by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Russia

Rest of Europe

Central & South America

Brazil

Rest of South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

Rest of Middle East & Africa

The study objectives are:

To analyze and research the global Healthcare Antimicrobial Plastics capacity, production, value, consumption, status and forecast;

To focus on the key Healthcare Antimicrobial Plastics manufacturers and study the capacity, production, value, market share and development plans in next few years.

To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Healthcare Antimicrobial Plastics :

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Global Healthcare Antimicrobial Plastics Market Research Report 2018-2025, by Manufacturers, Regions, Types and Applications

1 Study Coverage

1.1 Healthcare Antimicrobial Plastics Product

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Healthcare Antimicrobial Plastics Market Size Growth Rate by Type

1.4.2 Commodity Plastic

1.4.3 Engineering Plastic

1.4.4 High Performance Plastic

1.5 Market by Application

1.5.1 Global Healthcare Antimicrobial Plastics Market Size Growth Rate by Application

1.5.2 Hospital

1.5.3 Pharmacy

1.5.4 Household

1.5.5 Medical Research

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Healthcare Antimicrobial Plastics Production

2.1.1 Global Healthcare Antimicrobial Plastics Revenue 2013-2025

2.1.2 Global Healthcare Antimicrobial Plastics Production 2013-2025

2.1.3 Global Healthcare Antimicrobial Plastics Capacity 2013-2025

2.1.4 Global Healthcare Antimicrobial Plastics Marketing Pricing and Trends

2.2 Healthcare Antimicrobial Plastics Growth Rate (CAGR) 2018-2025

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Key Healthcare Antimicrobial Plastics Manufacturers

2.4 Market Drivers, Trends and Issues

2.5 Macroscopic Indicator

2.5.1 GDP for Major Regions

2.5.2 Price of Raw Materials in Dollars: Evolution

3 Market Size by Manufacturers

3.1 Healthcare Antimicrobial Plastics Production by Manufacturers

3.1.1 Healthcare Antimicrobial Plastics Production by Manufacturers

3.1.2 Healthcare Antimicrobial Plastics Production Market Share by Manufacturers

3.2 Healthcare Antimicrobial Plastics Revenue by Manufacturers

3.2.1 Healthcare Antimicrobial Plastics Revenue by Manufacturers (2013-2018)

3.2.2 Healthcare Antimicrobial Plastics Revenue Share by Manufacturers (2013-2018)

3.3 Healthcare Antimicrobial Plastics Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

4 Healthcare Antimicrobial Plastics Production by Regions

4.1 Global Healthcare Antimicrobial Plastics Production by Regions

4.1.1 Global Healthcare Antimicrobial Plastics Production Market Share by Regions

4.1.2 Global Healthcare Antimicrobial Plastics Revenue Market Share by Regions

4.2 United States

4.2.1 United States Healthcare Antimicrobial Plastics Production

4.2.2 United States Healthcare Antimicrobial Plastics Revenue

4.2.3 Key Players in United States

4.2.4 United States Healthcare Antimicrobial Plastics Import & Export

4.3 Europe

4.3.1 Europe Healthcare Antimicrobial Plastics Production

4.3.2 Europe Healthcare Antimicrobial Plastics Revenue

4.3.3 Key Players in Europe

4.3.4 Europe Healthcare Antimicrobial Plastics Import & Export

4.4 China

4.4.1 China Healthcare Antimicrobial Plastics Production

4.4.2 China Healthcare Antimicrobial Plastics Revenue

4.4.3 Key Players in China

4.4.4 China Healthcare Antimicrobial Plastics Import & Export

4.5 Japan

4.5.1 Japan Healthcare Antimicrobial Plastics Production

4.5.2 Japan Healthcare Antimicrobial Plastics Revenue

4.5.3 Key Players in Japan

4.5.4 Japan Healthcare Antimicrobial Plastics Import & Export

4.6 Other Regions

4.6.1 South Korea

4.6.2 India

4.6.3 Southeast Asia

5 Healthcare Antimicrobial Plastics Consumption by Regions

5.1 Global Healthcare Antimicrobial Plastics Consumption by Regions

5.1.1 Global Healthcare Antimicrobial Plastics Consumption by Regions

5.1.2 Global Healthcare Antimicrobial Plastics Consumption Market Share by Regions

5.2 North America

5.2.1 North America Healthcare Antimicrobial Plastics Consumption by Application

5.2.2 North America Healthcare Antimicrobial Plastics Consumption by Countries

5.2.3 United States

5.2.4 Canada

5.2.5 Mexico

5.3 Europe

5.3.1 Europe Healthcare Antimicrobial Plastics Consumption by Application

5.3.2 Europe Healthcare Antimicrobial Plastics Consumption by Countries

5.3.3 Germany

5.3.4 France

5.3.5 UK

5.3.6 Italy

5.3.7 Russia

5.4 Asia Pacific

5.4.1 Asia Pacific Healthcare Antimicrobial Plastics Consumption by Application

5.4.2 Asia Pacific Healthcare Antimicrobial Plastics Consumption by Countries

5.4.3 China

5.4.4 Japan

5.4.5 South Korea

5.4.6 India

5.4.7 Australia

5.4.8 Indonesia

5.4.9 Thailand

5.4.10 Malaysia

5.4.11 Philippines

5.4.12 Vietnam

5.5 Central & South America

5.5.1 Central & South America Healthcare Antimicrobial Plastics Consumption by Application

5.5.2 Central & South America Healthcare Antimicrobial Plastics Consumption by Countries

5.5.3 Brazil

5.6 Middle East and Africa

5.6.1 Middle East and Africa Healthcare Antimicrobial Plastics Consumption by Application

5.6.2 Middle East and Africa Healthcare Antimicrobial Plastics Consumption by Countries

5.6.3 Turkey

5.6.4 GCC Countries

5.6.5 Egypt

5.6.6 South Africa

6 Market Size by Type

6.1 Global Healthcare Antimicrobial Plastics Breakdown Dada by Type

6.2 Global Healthcare Antimicrobial Plastics Revenue by Type

6.3 Healthcare Antimicrobial Plastics Price by Type

7 Market Size by Application

7.1 Overview

7.2 Global Healthcare Antimicrobial Plastics Breakdown Dada by Application

7.2.1 Global Healthcare Antimicrobial Plastics Consumption by Application

7.2.2 Global Healthcare Antimicrobial Plastics Consumption Market Share by Application (2013-2018)

8 Manufacturers Profiles

8.1 BASF SE (Germany)

8.1.1 BASF SE (Germany) Company Details

8.1.2 Company Description

8.1.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.1.4 Healthcare Antimicrobial Plastics Product Description

8.1.5 SWOT Analysis

8.2 Bayer MaterialScience AG (Germany)

8.2.1 Bayer MaterialScience AG (Germany) Company Details

8.2.2 Company Description

8.2.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.2.4 Healthcare Antimicrobial Plastics Product Description

8.2.5 SWOT Analysis

8.3 The Dow Chemical Company (US)

8.3.1 The Dow Chemical Company (US) Company Details

8.3.2 Company Description

8.3.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.3.4 Healthcare Antimicrobial Plastics Product Description

8.3.5 SWOT Analysis

8.4 Clariant AG (Switzerland)

8.4.1 Clariant AG (Switzerland) Company Details

8.4.2 Company Description

8.4.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.4.4 Healthcare Antimicrobial Plastics Product Description

8.4.5 SWOT Analysis

8.5 Lonza Group AG (Switzerland)

8.5.1 Lonza Group AG (Switzerland) Company Details

8.5.2 Company Description

8.5.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.5.4 Healthcare Antimicrobial Plastics Product Description

8.5.5 SWOT Analysis

8.6 Microban International (US)

8.6.1 Microban International (US) Company Details

8.6.2 Company Description

8.6.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.6.4 Healthcare Antimicrobial Plastics Product Description

8.6.5 SWOT Analysis

8.7 Parx Plastic BV (The Netherlands)

8.7.1 Parx Plastic BV (The Netherlands) Company Details

8.7.2 Company Description

8.7.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.7.4 Healthcare Antimicrobial Plastics Product Description

8.7.5 SWOT Analysis

8.8 King Plastic Corporation (US)

8.8.1 King Plastic Corporation (US) Company Details

8.8.2 Company Description

8.8.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.8.4 Healthcare Antimicrobial Plastics Product Description

8.8.5 SWOT Analysis

8.9 Biocote (UK)

8.9.1 Biocote (UK) Company Details

8.9.2 Company Description

8.9.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.9.4 Healthcare Antimicrobial Plastics Product Description

8.9.5 SWOT Analysis

8.10 Milliken Chemical (US)

8.10.1 Milliken Chemical (US) Company Details

8.10.2 Company Description

8.10.3 Capacity, Production and Value of Healthcare Antimicrobial Plastics

8.10.4 Healthcare Antimicrobial Plastics Product Description

8.10.5 SWOT Analysis

8.11 Sanitized AG (Switzerland)

8.12 PolyOne Corporation (US)

8.13 Ticona Engineering Polymers (US)

8.14 DSM (Netherlands)

8.15 Doeflex-Vitapol (UK)

9 Production Forecasts

9.1 Healthcare Antimicrobial Plastics Production and Revenue Forecast

9.1.1 Global Healthcare Antimicrobial Plastics Production Forecast 2018-2025

9.1.2 Global Healthcare Antimicrobial Plastics Revenue Forecast 2018-2025

9.2 Healthcare Antimicrobial Plastics Production and Revenue Forecast by Regions

9.2.1 Global Healthcare Antimicrobial Plastics Revenue Forecast by Regions

9.2.2 Global Healthcare Antimicrobial Plastics Production Forecast by Regions

9.3 Healthcare Antimicrobial Plastics Key Producers Forecast

9.3.1 United States

9.3.2 Europe

9.3.3 China

9.3.4 Japan

9.4 Forecast by Type

9.4.1 Global Healthcare Antimicrobial Plastics Production Forecast by Type

9.4.2 Global Healthcare Antimicrobial Plastics Revenue Forecast by Type

10 Consumption Forecast

10.1 Consumption Forecast by Application

10.2 Healthcare Antimicrobial Plastics Consumption Forecast by Regions

10.3 North America Market Consumption Forecast

10.3.1 North America Healthcare Antimicrobial Plastics Consumption Forecast by Countries 2018-2025

10.3.2 United States

10.3.3 Canada

10.3.4 Mexico

10.4 Europe Market Consumption Forecast

10.4.1 Europe Healthcare Antimicrobial Plastics Consumption Forecast by Countries 2018-2025

10.4.2 Germany

10.4.3 France

10.4.4 UK

10.4.5 Italy

10.4.6 Russia

10.5 Asia Pacific Market Consumption Forecast

10.5.1 Asia Pacific Healthcare Antimicrobial Plastics Consumption Forecast by Countries 2018-2025

10.5.2 China

10.5.3 Japan

10.5.4 Korea

10.5.5 India

10.5.6 Australia

10.5.7 Indonesia

10.5.8 Thailand

10.5.9 Malaysia

10.5.10 Philippines

10.5.11 Vietnam

10.6 Central & South America Market Consumption Forecast

10.6.1 Central & South America Healthcare Antimicrobial Plastics Consumption Forecast by Country 2018-2025

10.6.2 Brazil

10.7 Middle East and Africa Market Consumption Forecast

10.7.1 Middle East and Africa Healthcare Antimicrobial Plastics Consumption Forecast by Countries 2018-2025

10.7.2 Middle East and Africa

10.7.3 Turkey

10.7.4 GCC Countries

10.7.5 Egypt

10.7.6 South Africa

11 Upstream, Industry Chain and Downstream Customers Analysis

11.1 Analysis of Healthcare Antimicrobial Plastics Upstream Market

11.1.1 Healthcare Antimicrobial Plastics Key Raw Material

11.1.2 Typical Suppliers of Key Healthcare Antimicrobial Plastics Raw Material

11.1.3 Healthcare Antimicrobial Plastics Raw Material Market Concentration Rate

11.2 Healthcare Antimicrobial Plastics Industry Chain Analysis

11.3 Marketing & Distribution

11.4 Healthcare Antimicrobial Plastics Distributors

11.5 Healthcare Antimicrobial Plastics Customers

12 Opportunities & Challenges, Threat and Affecting Factors

12.1 Market Opportunities

12.2 Market Challenges

12.3 Porter's Five Forces Analysis

12.4 Affecting Factors

13 Key Findings

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
Choose License Type



Why Choose Us

  24/7 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Email: sales@marketresearchplace.com

  Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

  Information security

Your personal and confidential information is safe and secure.